MOLNUPIRAVIR's Background
Molnupuravir (200 mg) is an antiviral agent that has been approved for the mild-to-moderate treatment of COVID-19. Coronavirus disease (Covid-19), also known as SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus 2), is a coronavirus-caused infectious disease. Its symptoms include fever and cough, which can progress to pneumonia and respiratory failure in some...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian
Portuguese (Brazil)
